fda deadline semaglutide crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many The Semaglutide Shortage Is Ending:

ASCO expert Chwistek said anti-inflammatory and immune-modulating properties have long suggested broader effects of GLP-1s

Cardiovascular Applications TB-500 has demonstrated significant cardiovascular benefits in preclinical investigations, particularly in models of myocardial injury and cardiac remodeling

These advancements promise not just weight loss but a transformative approach to wellness

The medical system was on the verge of collapse due to the obesity and pre-diabetes epidemics, but the introduction of GLP1s has provided a chance to dramatically change the rate of these conditions and related cardiovascular diseases 42s